| 产品名称: | NCI-H1882 H1882 |
|---|---|
| 商品货号: | TS211318 |
| Organism: | Homo sapiens, human |
| Tissue: | lung; Derived from metastatic site: bone marrow |
| Product Format: | frozen |
| Morphology: | epithelial |
| Culture Properties: | adherent |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease: | stage E,carcinoma; small cell lung cancer |
| Age: | 59 years |
| Gender: | male |
| Ethnicity: | Caucasian |
| Applications: | The line was established in April 1988. |
| Images: | |
| Derivation: | The line was established in April 1988. |
| Clinical Data: | The patient was a smoker. male Caucasian 59 years |
| Comments: | The line was established in April 1988. The patient was a smoker. 40 pack years. |
| Complete Growth Medium: | HITES medium supplemented with 5% fetal bovine serum
|
| Subculturing: | Protocol: Volumes used in this protocol are for 75 sq cm flasks; proportionally reduce or increase amount of dissociation medium for culture vessels of other sizes.
Subcultivation ratio: A subcultivation ratio of 1:2 to 1:6 twice weekly is recommended. Medium renewal: Every 2 to 3 days |
| Cryopreservation: | RPMI 1640, 85% ; FBS, 10%; DMSO, 5% |
| Culture Conditions: | Temperature: 37.0°C |
| STR Profile: | Amelogenin: X,Y CSF1PO: 11 D13S317: 12 D16S539: 12 D5S818: 11 D7S820: 10,12 THO1: 6 TPOX: 8,9 vWA: 17 |
| Name of Depositor: | AF Gazdar, JD Minna |
| Deposited As: | Homo sapiens |
| Year of Origin: | 1988 |
| References: | NCI-Navy Medical Oncology Branch Cell Line Supplement. J. Cell. Biochem. suppl. 24: 1996. |